Patents by Inventor Jean-Michel Lelias

Jean-Michel Lelias has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10324092
    Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.
    Type: Grant
    Filed: July 28, 2015
    Date of Patent: June 18, 2019
    Assignee: Eurofins DiscoverX Corporation
    Inventors: Pietro Ciceri, Jeremy Hunt, Jean-Michel A. Lelias, Mike Morrison, Daniel K. Treiber, Lisa Wodicka
  • Publication number: 20150377886
    Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.
    Type: Application
    Filed: July 28, 2015
    Publication date: December 31, 2015
    Inventors: Pietro Ciceri, Jeremy Hunt, Jean-Michel A. Lelias, Mike Morrison, Daniel K. Treiber, Lisa Wodicka
  • Patent number: 9110054
    Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.
    Type: Grant
    Filed: June 29, 2007
    Date of Patent: August 18, 2015
    Assignee: DiscoveRx Corporation
    Inventors: Pietro Ciceri, Jeremy Hunt, Jean-Michel A. Lelias, Mike Morrison, Daniel Treiber, Lisa Wodicka
  • Publication number: 20090053701
    Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.
    Type: Application
    Filed: June 29, 2007
    Publication date: February 26, 2009
    Applicant: Ambit Biosciences Corp.
    Inventors: Pietro Ciceri, Jeremy Hunt, Jean-Michel A. Lelias, Mike Morrison, Daniel Treiber, Lisa Wodicka
  • Patent number: 5972688
    Abstract: The invention relates to a recombinant DNA molecule which encodes a HT.sub.m4 protein, a transformed host cell which has been stably transfected with a DNA molecule which encodes a HT.sub.m4 protein and a recombinant HT.sub.m4 protein. The invention also relates to a method for detecting the presence of a hereditary atopy.
    Type: Grant
    Filed: December 19, 1997
    Date of Patent: October 26, 1999
    Assignee: Beth Israel Deaconess Medical Center
    Inventors: Bing Lim, Chaker N. Adra, Jean-Michel Lelias
  • Patent number: 5767073
    Abstract: The sequence, molecular structure and expression of a cDNA clone, denoted D4, of human and murine origin, preferentially expressed in hematopoietic cells is described herein. The human cDNA clone has been expressed in bacteria and the predicted 24 Kd protein purified. The protein has been used in studies of its biochemical function. As predicted on the basis of sequence, D4 can function as a GDP-dissociation inhibitor of at least several small GTP-binding proteins (CDC42 and rac). The D4 protein was used to generate a polyclonal antibody specific for the protein. The human cDNA was used to obtain several full length murine genomic clones. A clone has been analyzed and sequenced to use for the construction of a gene-targeting vector to produce animals deficient in D4 through disruption of the gene by homologous recombination. These animals can then be used as models for fundamental and applied research on the GTP-binding proteins.
    Type: Grant
    Filed: June 1, 1994
    Date of Patent: June 16, 1998
    Assignee: Beth Israel Hospital Association
    Inventors: Bing Lim, Jean-Michel Lelias, Chaker N. Adra, Jone L. Ko
  • Patent number: 5705615
    Abstract: The invention relates to a recombinant DNA molecule which encodes a HT.sub.m4 protein, a transformed host cell which has been stably transfected with a DNA molecule which encodes a HT.sub.m4 protein and a recombinant HT.sub.m4 protein. The invention also relates to a method for detecting the presence of a hereditary atopy.
    Type: Grant
    Filed: September 3, 1996
    Date of Patent: January 6, 1998
    Assignee: Beth Israel Deaconess Medical Center
    Inventors: Bing Lim, Chaker N. Adra, Jean-Michel Lelias
  • Patent number: 5585478
    Abstract: The sequence, molecular structure and expression of a cDNA clone, denoted D4, of human and murine origin, preferentially expressed in hematopoietic cells is described herein. The human cDNA clone has been expressed in bacteria and the predicted 24 Kd protein purified. The protein has been used in studies of its biochemical function. As predicted on the basis of sequence, D4 can function as a GDP-dissociation inhibitor of at least several small GTP-binding proteins (CDC42 and rac). The D4 protein was used to generate a polyclonal antibody specific for the protein. The human cDNA was used to obtain several full length murine genomic clones. A clone has been analyzed and sequenced to use for the construction of a gene-targeting vector to produce animals deficient in D4 through disruption of the gene by homologous recombination. These animals can then be used as models for fundamental and applied research on the GTP-binding proteins.
    Type: Grant
    Filed: August 18, 1994
    Date of Patent: December 17, 1996
    Assignee: Beth Israel Hospital Association
    Inventors: Bing Lim, Jean-Michel Lelias, Chaker N. Adra, Jone L. Ko
  • Patent number: 5552312
    Abstract: The invention relates to a recombinant DNA molecule which encodes a HT.sub.m4 protein, a transformed host cell which has been stably transfected with a DNA molecule which encodes a HT.sub.m4 protein and a recombinant HT.sub.m4 protein. The invention also relates to a method for detecting the presence of a hereditary atopy.
    Type: Grant
    Filed: October 6, 1994
    Date of Patent: September 3, 1996
    Assignee: Beth Israel Hospital Boston
    Inventors: Bing Lim, Chaker N. Adra, Jean-Michel Lelias